AVENUE THERAPEUTICS, INC. Dilutive Share Adjustment
AVENUE THERAPEUTICS, INC. (ATXI) reported Dilutive Share Adjustment of 1.32 million shares for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-13.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment · last filed 2019-05-13
- AVENUE THERAPEUTICS, INC. weighted average number diluted shares outstanding adjustment for the quarter ending 2019-03-31 was 1.32M shares, a 33.53% increase year-over-year.
- AVENUE THERAPEUTICS, INC. weighted average number diluted shares outstanding adjustment for the quarter ending 2018-12-31 was 1.32M shares, a 34.48% increase year-over-year.
- AVENUE THERAPEUTICS, INC. weighted average number diluted shares outstanding adjustment for the quarter ending 2018-09-30 was 2.29M shares, a 11.30% increase year-over-year.
- AVENUE THERAPEUTICS, INC. weighted average number diluted shares outstanding adjustment for the quarter ending 2018-06-30 was 901.66K shares, a 140.44% increase year-over-year.
- AVENUE THERAPEUTICS, INC. weighted average number diluted shares outstanding adjustment for fiscal 2018 was 1.37M shares, a 39.56% increase from fiscal 2017.
- AVENUE THERAPEUTICS, INC. weighted average number diluted shares outstanding adjustment for fiscal 2017 was 985.00K shares, a 87.62% increase from fiscal 2016.
- AVENUE THERAPEUTICS, INC. weighted average number diluted shares outstanding adjustment for fiscal 2016 was 525.00K shares.
| Period end | Weighted Average Number Diluted Shares Outstanding Adjustment 3 month | Weighted Average Number Diluted Shares Outstanding Adjustment 6 month | Weighted Average Number Diluted Shares Outstanding Adjustment 9 month | Weighted Average Number Diluted Shares Outstanding Adjustment 11 month | Weighted Average Number Diluted Shares Outstanding Adjustment 12 month |
|---|---|---|---|---|---|
| 2019-03-31 | 1.32M shares 10-Q · filed 2019-05-13 | 1.32M shares derived: average of 2 quarters · filed 2019-05-13 | 1.64M shares derived: average of 3 quarters · filed 2019-05-13 | 1.46M shares derived: average of 4 quarters · filed 2019-05-13 | |
| 2018-12-31 | 1.32M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | 1.81M shares derived: average of 2 quarters · filed 2019-03-12 | 1.50M shares derived: average of 3 quarters · filed 2019-03-12 | 1.37M shares 10-K · filed 2019-03-12 | |
| 2018-09-30 | 2.29M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | 1.59M shares derived: average of 2 quarters · filed 2018-11-14 | 1.39M shares 10-Q · filed 2018-11-14 | 1.29M shares derived: average of 4 quarters · filed 2019-05-13 | |
| 2018-06-30 | 901.66K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | 943.33K shares 10-Q · filed 2018-08-14 | 957.22K shares derived: average of 3 quarters · filed 2019-05-13 | 1.23M shares derived: average of 4 quarters · filed 2019-05-13 | |
| 2018-03-31 | 985.00K shares 10-Q · filed 2019-05-13 | 985.00K shares derived: average of 2 quarters · filed 2019-05-13 | 1.34M shares derived: average of 3 quarters · filed 2019-05-13 | 1.10M shares derived: average of 4 quarters · filed 2019-05-13 | |
| 2017-12-31 | 985.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | 1.52M shares derived: average of 2 quarters · filed 2019-03-12 | 1.14M shares derived: average of 3 quarters · filed 2019-03-12 | 985.00K shares 10-K · filed 2019-03-12 | |
| 2017-09-30 | 2.05M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | 1.21M shares derived: average of 2 quarters · filed 2018-11-14 | 985.00K shares 10-Q · filed 2018-11-14 | ||
| 2017-06-30 | 375.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | 450.00K shares 10-Q · filed 2018-08-14 | |||
| 2017-03-31 | 525.00K shares 10-Q · filed 2018-05-03 | ||||
| 2016-12-31 | 525.00K shares 10-K · filed 2018-03-01 | ||||
| 2015-12-31 | 366.67K shares 10-K · filed 2018-03-01 |